ScholarIQanswers from OpenAlex

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation

PaperCitations, authors & open-access status

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation have?

ScholarIQcitation count

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation has 1,684 citations in the OpenAlex counts ScholarIQ stores.

When was Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation published?

ScholarIQyear

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation has 2014 year in the ScholarIQ index.

What is the open-access status of Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation?

ScholarIQoa status

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation has bronze oa status in the ScholarIQ index.

What is the DOI of Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation?

ScholarIQdoi

The DOI for Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation is on the source record.

What is the PMID of Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation?

ScholarIQpmid

The PMID for Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation is on the source record.

What is the OpenAlex record for Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation?

ScholarIQopenalex

The OpenAlex for Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial